Clin2
NCT06635525Possibly a fitRecruiting

How kidney failure affects your flu shot response

Chronic Kidney Disease Requiring Chronic DialysisVaccine Response

Treatments studied

Part of Infections, Kidney & urinary, Lungs & breathing, Women’s health & pregnancy clinical trials.

This study looks at how well the flu vaccine works in people with kidney failure who are on dialysis compared to healthy people. It will help doctors understand how kidney problems affect the body’s immune response to vaccination.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
146 people
Ages
18 years to 70 years
Study type
Observational

Who can take part

  • You are between 18 and 70 years old.
  • You either have been on dialysis (hemodialysis or peritoneal dialysis) for at least 3 months, or you are a healthy person without kidney disease.
  • You are eligible to get the seasonal flu shot.
  • You are willing to sign a consent form to join the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06907667Recruiting
Do timing of flu shot affect protection in kidney failure?

This study looks at whether getting a flu shot at a different time of day affects how well it works in people with chronic kidney failure, including those on dialysis or with a kidney transplant. Researchers want to see if timing can improve the body's immune response to the vaccine.

Nice, Alpes-Maritimes
NCT07587801Not yet recruiting· Phase 2
Boosting Vaccine Response in Dialysis Patients Over 60

This study tests whether a medication called rapamycin (sirolimus) can help improve your body's response to flu and RSV vaccines. You have end-stage kidney disease and receive dialysis three times a week, and the researchers want to see if this approach keeps you safer from these infections.

Camperdown, New South Wales
NCT04579588Recruiting
Study flu vaccine immunity in people after COVID-19

This study looks at how well your immune system (your body’s infection-fighting system) responds to a flu vaccine after you’ve had COVID-19. It may help doctors understand why some people have different protection after vaccines.

Palo Alto, California
NCT05947071Recruiting· Phase 2
Higher-dose flu vaccine versus standard dose in child transplant patients

This trial compares a higher-dose flu vaccine to the standard dose in children who recently received a kidney, heart, and/or liver transplant. It aims to see which dose better protects children against influenza while checking for safety.

Stanford, California
NCT07240558Recruiting· Phase 3
Flu vaccine study for organ transplant patients

This study tests whether a special flu vaccine, designed for a future pandemic, works safely in people who have had an organ transplant. It aims to find a better way to protect transplant patients from severe flu.

Toronto, Ontario
NCT05291676Recruiting· Phase 2
Study how vaccines work in aging and frailty adults

This trial studies how well your immune system responds to a vaccine in people who are younger adults or, especially, older adults and those with frailty. Your participation may help researchers understand why vaccine responses can differ with age.

New Haven, Connecticut

Hear when a new Chronic Kidney Disease Requiring Chronic Dialysis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.